ArticleCancer letters2023

SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.

Anthony Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.